Pharming Group (OTCMKTS:PHGUF) Shares Cross Above 50 Day Moving Average – Time to Sell?

Pharming Group (OTCMKTS:PHGUF) crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $0.81 and traded as high as $0.99. Pharming Group shares last traded at $0.98, with a volume of 3,000 shares traded.

Pharming Group Stock Performance

The stock’s 50 day moving average price is $0.81 and its two-hundred day moving average price is $0.81. The company has a current ratio of 3.53, a quick ratio of 2.76 and a debt-to-equity ratio of 0.53. The firm has a market capitalization of $640.67 million, a price-to-earnings ratio of -49.10 and a beta of 1.11.

Pharming Group Company Profile

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.